Results 61 to 70 of about 524,828 (227)
Reliable and accurate diagnostics from highly multiplexed sequencing assays [PDF]
, 2020 Scalable, inexpensive, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays (HMSAs) that rely on high-throughput sequencing can, in principle, meet ...
Bloom, Joshua S. +8 more
core
Molecular Crowding Modulates SARS‐CoV‐2 Aptamer Affinity
Small Structures, 2023 SARS‐CoV‐2 aptamer is a favorable candidate for the recognition and detection of SARS‐CoV‐2, owing to its small size and easy synthesis. However, the issue of compromised binding affinities in real samples and targeting mutant SARS‐CoV‐2 hinder wide ...
Ting Song +6 more
doaj +1 more source
Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces
, 2020 SARS-CoV-2 survives and remains viable on surfaces for several days under different environments as reported in recent studies. However, it is unclear how the viruses survive for such a long time and why their survivability varies across different ...
He, Zilong +5 more
core +1 more source
Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic [PDF]
, 2020 Importance The rapidly expanding novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has challenged the medical community to an unprecedented degree.
Chinn, Steven B. +13 more
core +1 more source
Erythema Multiforme Major following SARS‐CoV‐2 vaccine
Clinical Case Reports, 2021 Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene +7 more
doaj +1 more source
Zeitschrift für Rheumatologie, 2020 Zusammenfassung Die Empfehlungen des Deutschen Gesellschaft für Rheumatologie(DGRh)-Updates – welches die zu Beginn der COVID-19-Pandemie erstellte Hilfestellung zum Management von Patienten mit entzündlich rheumatischen Erkrankungen angesichts der Bedrohung durch SARS-CoV‑2 aktualisiert und erweitert – stimmen in vielen Punkten mit den ...
Leipe, J. +5 more
openaire +2 more sources
Electronic Health Record-Based Surveillance for Community Transmitted COVID-19 in the Emergency Department [PDF]
, 2020 Introduction: SARS-CoV-2, a novel coronavirus, manifests as a respiratory syndrome (COVID-19) and is the cause of an ongoing pandemic. The response to COVID-19 in the United States has been hampered by an overall lack of diagnostic testing capacity.
Barclay-Buchanan, Ciara +8 more
core
Infection Prevention in PracticeSummary: Background: During the SARS-CoV-2 pandemic, dominant viral variants were repeatedly replaced by new variants with altered properties, frequently changing the dynamics of the infection event, as well as the effectiveness of vaccines and ...
Hanno Schmidt +11 more
doaj +1 more source
SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage
Clinical Case Reports, 2022 A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva +6 more
doaj +1 more source
SARS CoV- 2 vaccination induces antibodies against cardiolipin
BMC Research Notes, 2022 Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias +5 more
doaj +1 more source